The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Pelabresib, a bromodomain and extraterminal domain inhibitor, plus ruxolitinib (a Janus kinase [JAK] inhibitor) improves ...

ABIVAX is a French biotech with a novel ulcerative colitis treatment in phase 3 trials. Click here to find out why I am ...

Researchers examined the risk for serious infection among patients with atopic dermatitis treated with Janus kinase inhibitors vs Th2 cytokine inhibitors.

In immune-mediated inflammatory diseases, the overall risk for serious adverse events is not notably higher with combo ...

HONG KONG SAR - Media OutReach Newswire - 27 March 2025 - At today's press conference, members of the education expert panel on vitiligo, including Dr Johnny Chan Chun-yin, ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers at the University of Wisconsin–Madison.

A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...